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Abstract
Clostridiodes difficile (C. difficile) was ranked an “urgent threat” by the Centers for Disease
Control and Prevention (CDCAU : PleasenotethatCDChasbeendefinedasCentersforDiseaseControlandPreventionintheAbstractandinthemaintext:Pleasecorrectifnecessary:) in 2019. C. difficile infection (CDI) is the most c mmon
healthcare-associated infection (HAI) in the United States of America as well as the leading
cause of antibiotic-associated gastrointestinal disease. C. difficile is a gram-positive, rod-
shaped, spore-forming, anaerobic bacterium that causes infection of the epithelial lining of
the gut. CDI occurs most commonly after disruption of the human gut microflora following
the prolonged use of broad-spectrum antibiotics. However, the recurrent nature of this dis-
ease has led to the hypothesis that biofilm formation may play a role in its pathogenesis. Bio-
films are sessile communities of bacteria protected from extracellular stresses by a matrix of
self-produced proteins, polysaccharides, and extracellular DNA. Biofilm regulation in C. diffi-
cile is still incompletely understood, and its role in disease recurrence has yet to be fully elu-
cidated. However, many factors have been found to influence biofilm formation in C. difficile,
including motility, adhesion, and hydrophobicity of the bacterial cells. Small changes in one
of these systems can greatly influence biofilm formation. Therefore, the biofilm regulatory
system would need to coordinate all these systems to create optimal biofilm-forming physiol-
ogy under appropriate environmental conditions. The coordination of these systems is com-
plex and multifactorial, and any analysis must take into consideration the influences of the
stress response, quorum sensing (QS), and gene regulation by second messenger mole-
cule cyclic diguanosine monophosphate (c-di-GMP). However, the differences in biofilm-
forming ability between C. difficile strains such as 630 and the “hypervirulent” strain,
R20291, make it difficult to assign a “one size fits all” mechanism to biofilm regulation in C.
difficile. This review seeks to consolidate published data regarding the regulation of C. diffi-
cile biofilms in order to identify gaps in knowledge and propose directions for future study.
Author summary
Clostridioides difficile (C. difficile) is an opportunistic bacterial pathogen that causes infec-
tion of the human gut epithelium following disruption of the normal gut microflora,
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usually by broad-spectrum antibiotics. C. difficile infection (CDI) is recurrent in 20% to
30% of cases and can lead to significant health-related complications such as pseudomem-
branous colitis and, in severe cases, death. The impact and cost of this pathogen on health-
care systems are significant, and some aspects of the pathogen’s lifestyle in the host are, as
yet, unknown. It is hypothesised that C. difficile exists in the gut as a biofilm due to the
infection’s severity and recurrent nature. The biofilm mode of bacterial growth can pro-
tect the cells from external factors such as antibiotic treatment, physiological processes,
and the immune system. However, biofilm regulation in C. difficile is not yet fully charac-
terised, and in this review, we consolidate published primary research on C. difficile bio-
film regulation to gain a comprehensive overview of the factors involved and how they
may interact to enable biofilm development within a host.
Introduction
Clostridioides difficile (C. difficile) is a gram-positive, rod-shaped, obligatory anaerobic bacte-
rium with a low genome GC content (630 GC = 29.06%) [1]. This spore-forming anaerobe is
found asymptomatically in 1% to 3% of healthy adult humans [2]. Additionally, it is also found
in many other animals including diverse mammals, reptiles, and birds, all with the potential
for zoonotic transfer to humans (for further consideration of this aspect, readers are referred
to the following recent reviews [3–5]). Broad-spectrum antibiotic treatment can disrupt the
normal microbiota in the gut causing dysbiosis of the gut microbiome [6,7]. This presents an
opportunity for the rapid growth of C. difficile, leading to C. difficile infection (CDI) [2].
C. difficile has been ranked an “urgent threat” by the Centers for Disease Control and Pre-
vention (CDC) in 2019 as it is the most common cause of healthcare-associated infection
(HAI) in the United States of America [8,9] as well as the leading cause of antibiotic-associated
gastrointestinal disease [9,10]. However, CDI has become increasingly prevalent as a commu-
nity associated infection in younger, healthier patients [11,12]. Recent data on the impact of C.
difficile in Europe and, specifically, the United Kingdom, are limited and have been described
as urgently needed [13]. An epidemiological study on HAIs conducted between 2016 to 2017
found almost 45% of healthcare-associated gastrointestinal infections in Europe were caused
by C. difficile [14].
The recurrent nature of CDI, affecting 20% to 30% of cases, adds to the already significant
health service costs associated with treatment of this infection [15–17]. The real global impact
of CDI is unclear; however, considering the US reported half a million CDI cases and 29,000
deaths in 2012, with an average annual cost between US$5.4 and US$6.3 billion [18], it is esti-
mated to be significantly higher than this (for a comprehensive review, please see [19]).
It has been hypothesised that C. difficile’s virulence and recurrence are due to its ability to
form biofilms in the gut [20]. Biofilms (Fig 1) are sessile communities of microbes living
within self-produced, hydrated extracellular matrices generally composed of proteins, polysac-
charides, and nucleic acids [21–24]. The specific structural and compositional properties of a
biofilm depend on the bacterial species, which produces the biofilm, and the environmental
conditions it is exposed to [25,26]. Infections where bacteria form biofilms are characterised as
persistent, chronic, and extremely difficult to treat due to the biofilms’ inherent increase in
antibiotic resistance [27,28].
C. difficile has been successfully grown in multispecies biofilms in vivo with species repre-
sentative of the human gut microbiome [30]. The in vitro human gut model found C. difficile
spores could be conserved within the multispecies biofilms to cause recurrence [30]. In vivo
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studies using animal models have also shown that C. difficile is capable of forming multicellular
structures such as microbial aggregates in the gut [31–34].
Further indication that C. difficile biofilms are important in pathogenesis of disease is the
observation that bile salts such as deoxycholate (DOC), in the presence of fermentable sugars
found in the gut, can significantly increase biofilm formation as a mechanism of the stress
response [35]. Several factors influence bacterial ability to form biofilms, including adherence
and motility [36–39]. Development of mutant strains of C. difficile and their use as models to
assess the resulting effects of the mutations on biofilm formation have led to some understand-
ing of how biofilms are regulated in C. difficile [20,40–44]. The aim of this review, therefore, is
to consolidate and critically analyse published information on the factors known to regulate
biofilm formation. We intend to provide the scientific community with a comprehensive
understanding of what coordinates the necessary cellular features within C. difficile to create
optimal conditions for biofilm formation.
Cells in a sessile state
Cells within biofilms are described as being in a nonmotile, sessile state where they are
attached to a surface. The switch between motile and sessile lifestyles in a wide range of bacte-
ria—including C. difficile—is controlled by second messenger molecule, cyclic diguanosine
monophosphate (c-di-GMP) [39]. c-di-GMP controls gene expression by acting on ribos-
witches located upstream of the controlled genes [39,45–47]. Riboswitch Cdi-1-3 is activated
by c-di-GMP to down-regulate the FlgB operon containing 29 flagellar genes in the switch
from motile to sessile lifestyle [45].
However, flagellar expression is also controlled by phase variation in all C. difficile strains
except 630, which is effectively locked in a “flagella on” state [48]. Low levels of intracellular c-di-
GMP allow for transcription of the downstream inversion site named Cdi4 in strain R20291,
which can change between an “on” or “off” position [48]. DNA inversion by site-specific recombi-
nation of Cdi4 located upstream of the flgB operon into the “flagella off” position down-regulates
flagellar expression by posttranscriptionally destabilising or degrading the mRNA potentially by a
trans-acting element, thereby inhibiting flagellar expression on the cell surface [48].
Flagella are primarily responsible for the swimming motility of C. difficile in planktonic cul-
tures [49–51]. Investigations of gene expression in established C. difficile biofilms compared to
Fig 1. StagesAU : PleasechangeAdherancetoAdherenceinFig1andprovideanewFig1file:of biofilm formation. F ee-floating pla ktonic cells adhere to a surface and begin microcolony formation with production of a hydrated extracellular matrix
of proteins, polysaccharides, and nucleic acids. A mature biofilm may contain subpopulations of cells existing in various states where dispersion of the biofilm may occur
due to physical disruption or cell signalling. Adapted from [29]. Created with BioRender.com.
https://doi.org/10.1371/journal.ppat.1009817.g001
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planktonic cultures agree that flagellar genes are decreased in expression in biofilms [38,52].
Hypervirulent C. difficile strain R20291, originally isolated from an outbreak in Stoke Mande-
ville Hospital, UK, formed biofilms with visibly reduced expression of flagella when grown for
7 days on glass beads [38,53]. This was reflected by a significant reduction in expression of the
major flagellar filament gene, fliC, by 2.54-fold when compared to planktonic counterparts,
indicating that flagella are down-regulated in an established biofilm [38]. Expression of several
other flagellar biosynthesis genes were decreased in a 72-hour 630Δerm biofilm including flhA,
flbD, flgE, and flgD, again showing that down-regulation of flagella components are required
for biofilm formation [52]. It is unsurprising that flagella would be down-regulated when
entering a sessile state, such as biofilm formation, as flagellar assembly and production is an
energetically expensive process [54].
In contrast, Dapa and colleagues suggested that flagella play an important role in the late
stages of biofilm formation as an R20291 fliC ClosTron disruption mutant exhibited decreased
biofilm after 5 days compared to the parent strain [36]. However, Valiente and colleagues
found that their R20291 fliC ClosTron mutant cells were completely lacking in flagella but had
formed aggregates and mature 6-day biofilms similar to the parent R20291 strain [55]. The dif-
ferences in these studies could be a result of a difference in the mutations, growth conditions,
or indeed be related to the vigour of washing planktonic cells from biofilms.
Further investigations into specific glycan modifications of C. difficile flagella have also
been undertaken via ClosTron mutagenesis of several glycosyltransferase genes, which are
responsible for type B posttranscriptional modifications of flagella in ribotype 027 strains of C.
difficile, including strain R20291 [55]. Type B modifications add glycan chains to flagella con-
taining O-linked N-acetyl hexosamine, 2 rhamnoses with or without methylation, and a novel
sulfonated peptidyl amidoglycan [55]. The addition of these glycan chains did not affect flagel-
lar assembly in cells of R20291 but appeared to significantly increase biofilm formation and
aggregation [55]. This was suggested to be due to an increase in cell hydrophobicity in the
mutant C. difficile R20291 that lacked this particular flagellar posttranscriptional modification
[55]. Only 2 of the 5 mutants created exhibited reduced motility, yet all 5 mutants showed a
similar increase in biofilm formation. Valiente and colleagues thus concluded that motility
does not heavily influence biofilm formation, but hydrophobicity, arising from the presence of
glycan chains on the flagella, could enhance biofilm formation through increased aggregation
[55].
Cell surface components and adherence in C. difficile biofilms
Poquet and colleagues analysed expression of genes associated with the biosynthetic pathways
of certain cell surface components in biofilm and planktonic 630Δerm using microarray analy-
sis of extracted RNA. They concluded that both the cell envelope and cell wall are modelled
differently in biofilms compared to planktonic cells due to an up-regulation of phospholipid
metabolism, Acyl Carrier proteins and fatty acid synthesis in the biofilm model [52]. This is
similar to biofilm formation processes in Bacillus subtilis, in which fatty acid synthesis is
required to build a hydrophobic environment within the biofilm in order to hold the complex
structure together [56].
Membrane-bound glycopolymers such as PSII (Polysaccharide II) teichoic acids are con-
served polysaccharide antigens, expressed at the cell surface of C. difficile [52,57]. The lcpB
gene is involved in depositing PSII teichoic acids at the cell surface, and its expression was
increased by 24.93-fold in 72-hour 630Δerm biofilm cells compared to planktonic cells [52].
This could be significant as a ClosTron mutation in the lcpB gene in strain 630Δerm signifi-
cantly increased biofilm formation at 24 hours (p< 0.05), a phenotypic effect that was partially
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restored by complementation of the lcpB gene [44]. The lcpB mutant exhibited elongation and
thickening of the cells along with curvature, abnormalities in septa, and slower, suboptimal
growth phenomena, which have been seen in other C. difficile mutants exhibiting increased
biofilm formation [41,44,58]. This could indicate that, although the lcpB gene itself does not
regulate biofilm formation, the changes to the cell surface caused by the mutation could influ-
ence biofilm formation via knock-on effects on hydrophobicity of the cell surface and resultant
cellular aggregation, similar to those observed in flagellar protein (FliC) mutants [55].
Other cell surface structures such as type IV pili are also known to influence biofilm forma-
tion in C. difficile, specifically with regard to their role in initial surface adherence
[21,22,38,59,60]. Like the flagellar operon, the pilA1 major pilin gene (CD3513) is positively
regulated by c-di-GMP acting on the upstream riboswitch, Cdi-2-4 (Fig 2) [45,60]. The pilA1
gene was up-regulated in 1-week-old biofilms along with pilK, pilU, and pilV when compared
to planktonic growth in C. difficile R20291 [38]. A pilA1 disruption mutant of R20291 was cre-
ated that had no visible pili and that produced thinner biofilms—measured by confocal
microscopy—with critically reduced biomass at a 24-hour time point [38]. However, by day 7,
Fig 2. Regulation of cell surface components under high intracellular levels of c-di-GMP acting on specific riboswitches (purple). Down-regulated components in
the presence of increased intracellular c-di-GMP are shown in red to include flagella and PPEP-1, which is responsible for cleavage of CD2831 and CD3246. Up-
regulated components are shown in green, namely CD2831, CD3246, and PilA1, causing an increase in surface PilA1 structures. Created with BioRender.com. c-diAU : AbbreviationlistshavebeencompiledforthoseusedinFigs2and3:Pleaseverifythatallentriesarecorrect:-
GMP, cyclic diguanosine monophosphate.
https://doi.org/10.1371/journal.ppat.1009817.g002
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there was no significant difference in biofilm biomass or thickness between the pilA1 mutant
and the R20291 parent strain [38]. This led to the conclusion that pili are required for initial
biofilm formation, most likely in the adhesion step [59], but not in the late stages of biofilm
formation [38]. A similar effect was also seen in P. aeruginosa where, although pili-driven
motility was not essential, it positively contributed to biofilm formation [61]. Further investi-
gation of gene expression in the pilA1 mutant at the point of adherence could help elucidate
which putative adhesins are up-regulated to compensate for the lack of pili and which led to
wild-type (WT) levels of biofilm formation in C. difficile R20291 at 7 days.
A separate study investigating gene expression in 630Δerm biofilms at 72 hours grown in a
microfermentor found that the genes for type IV pili biogenesis, including pliA, were up-regu-
lated compared to planktonic cells (Table 1), in a similar pattern to that observed in 7-day-old
R20291 biofilms [38,52]. However, a separate study has shown that although type IV pili affect
biofilm formation in both 630Δerm and R20291, they are of more critical importance in the
latter as there was a higher promoter activity of the pilA1 gene in R20291 [60]. This has led to
Table 1. Cell surface associated component genes’ expression in 630Δerm 72-hour biofilm cells, compared to
planktonically grown cells.
Gene ID Gene name Gene function/product Fold change
Fatty acid biogenesis
CD1183 acpP ACP 9.92
CD1062 acpP ACP 9.45
Cell wall
CD2766 lcpB Ligase anchoring polysaccharide to the cell wall 24.93
CD2762 uppS Putative undecaprynyl phosphate synthetase −1.23
Exported proteins
CD2831 Putative adhesin 6.77
CD2830 zmp1 Extracellular zinc metalloprotease −1.16
CD0873 Adhesin and sugar binding lipoprotein (ABC transport) 65.34
Type IV pili biogenesis
CD3513 pilA1 Putative pilin protein 6.11
CD2305 pilW Putative pilin protein 11.31
CD3504 Putative type IV prepilin peptidase, A24A family 6.45
CD3506 Conserved hypothetical protein 6.19
CD3507 Putative type IV pilin 10.78
CD3508 Putative type IV pilin 12.91
CD3509 Putative type IV pilus assembly protein 10.13
CD3510 Putative membrane protein 9.78
CD3511 Putative type IV pilus secretion protein 9.25
Flagellum biogenesis
CD0234 csrA Carbon storage regulator homolog CsrA −1.35
CD0254 flgD Basal-body rod modification protein FlgD −1.24
CD0255 flgE Flagellar hook protein FlbE (distal rod protein) −1.29
CD0255A flbD Flagellar protein FlbD −1.28
CD0263 flhA Flagellar biosynthesis protein FlhA −1.19
630Δerm biofilm was grown in a continuous flow microfermentor for 72 hours with gene expression measured by
microarray. Negative integers represent decreased expression. (Data from [52] transformed to show absolute fold
changes).
ACPAU : AbbreviationlistshavebeencompiledforthoseusedinTables1and2:Pleaseverifythatallentriesarecorrect:, acyl carrier pro ei .
https://doi.org/10.1371/journal.ppat.1009817.t001
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the suggestion that the significantly increased expression of pilA1 in R20291 biofilms when
compared to planktonic culture, and which was not observed in the 630Δerm model, is respon-
sible for the increased biofilm-forming capability of R20291, which has also been reported in
previous studies [36,41,60]. However, reports of 630 and 630Δerm biofilms with significantly
greater biofilm biomass than R20291 have also been published, which could highlight the need
for standardised methods for biomass measurement [20,62].
Additional proteins with an adhesin function in C. difficile including cwp66 and CD0802
were both down-regulated in 7-day-old R20291 biofilms propagated on glass coverslips com-
pared to planktonic cells [38]. Expression of the cell wall–binding cysteine protease, cwp84,
wasn’t significantly different between the biofilm and planktonic grown cells of strain R20291
[38]; however, when the gene was disrupted by a ClosTron insertion in this strain, biofilm for-
mation was dramatically decreased at 1, 3, and 5 days (p< 0.05) [36]. Alternatively, another
study in 630Δerm measured a significant increase in biofilm formation by a cwp84 mutant
(p< 0.05) [37]. This may indicate that cwp84, like pilA1, is regulated differently in 630Δerm
and R20291 [60] and therefore could play a more significant role in R20291 biofilm formation.
A comparative controlled study would be required to investigate this.
The Cwp84 protease is also responsible for cleavage of SlpA into the 2 S-layer protein sub-
units that form the outer S-layer cover on vegetative C. difficile cells [63–65]. Richards and col-
leagues investigated the influence of the S-layer on biofilm formation by creating deletion
mutations in the SLCT-11 S-layer cassette of C. difficile strain Ox247 (ribotype 005) [40].
Mutations in orf2, orf3, orf4, orf7, orf16, and orf19 of the SLCT-11 caused an average decrease
in cell length of approximately 15%, and the ability to sporulate was eliminated in orf2 and
orf19 mutants [40]. While the orf2 mutant was more weakly adherent to Caco-2 cells, it was
the only mutant that formed significantly more biofilm in 24-well microtiter plates at 24- and
72-hour time points compared to the parent strain (p< 0.05) as quantified using the crystal
violet assay [40]. It was concluded that the effects on biofilm formation of mutating cwp84 in
C. difficile were not due to the effect this has on SlpA [36,37,40].
Several cell surface associated proteins in C. difficile are regulated by c-di-GMP including
CD2795 (cell wall binding protein, Cwp11), CD2796 (cell surface protein, Cwp10), and
CD2797 (calcium-binding adhesion protein) [45]. CD2795, encoding Cwp11, has been identi-
fied as a protein released in the “secretome” during biofilm formation, while cwp10 expression
was found to be increased by 9.13-fold in 630Δerm biofilms when compared with planktonic
cells [37,52].
Cell wall adhesin CD2831 is characterised as a microbial surface component recognising
adhesive matrix molecule (MSCRAMM) as it has been found to bind to immobilised collagen
on ELISA plates [39]. CD2831 and CD3246 are both cell surface proteins positively regulated
by c-di-GMP through riboswitches Cdi-2-3 and Cdi-2-1, respectively [45,62]. Both are cleaved
from the cell surface by CD2830, a zinc-dependent metalloprotease (Zmpl) named PPEP-1
(pro-pro endopeptidase), which is negatively regulated by c-di-GMP acting on riboswitch
Cdi-1-12 [39,62,66,67]. Cdi-2-1 up-regulates CD3246, a cell surface protein that produced a
significant increase in biofilm formation when expressed ectopically using an inducible plas-
mid [45].
CD2830 was found to be the most down-regulated gene—by 62.61-fold—when c-di-GMP
levels were artificially increased using an inducible plasmid, whereas CD2831 was the most
up-regulated gene (by 42.51-fold) [45]. This correlates well with observations of gene expres-
sion in 630Δerm biofilm compared to planktonic cells (Table 1), where CD2831 expression
increased by 6.77-fold and CD2830 expression decreased by 1.16-fold [52].
Overexpression of CD2831 using an inducible promoter on a plasmid increased 630Δerm
biofilm proportionately [39]. Similarly, a ClosTron mutant of CD2831 in strain 630 showed a
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significant reduction in early biofilm at 24 hours (p< 0.05) but did not exhibit significant
effects on attachment or late biofilm formation [62]. This mutation could be complimented
using an inducible plasmid containing the CD2831 gene to restore biofilm to the original phe-
notype [62]. Furthermore, increased expression of CD2831 or CD3246 using an inducible plas-
mid in a PPEP-1 mutant of strain 630 caused a significant increase in early biofilm formation
((p< 0.01) or (p< 0.05), respectively) [62].
Other cell surface structures, namely CD3392, CD0183, and CD3145, which are not regu-
lated by c-di-GMP, also produced significant reductions in biofilm formation (p< 0.01,
p< 0.001, and p< 0.05, respectively) when genetically disrupted by ClosTron mutagenesis
[62]. CD3392 is a cell wall protein containing an SPKTG motif anchored to the cell wall via
sortase, which was present in the biofilm matrix of strain 630Δerm [62]. Whereas CD0183 and
CD3145 (CbpA) are anchored to the cell wall independently of sortase but contain SPSTG and
SPQTG motifs, respectively [62,68]. A role for CD0183 and CbpA in biofilm formation has yet
to be determined [47,62,69]; however, CbpA is a novel cell surface exposed adhesin with a high
affinity for binding to collagens I and V [62,69], and CD0183 with suspected autolytic proper-
ties has been shown to be positively controlled by small RNA RCd2, which itself is induced
when cells enter exponential growth phase [47].
Taken together, the above observations by a range of independent groups suggest that
CD2831 and CbpA could play a role in pathogenesis by binding to native collagen-producing
cells found on the host extracellular matrix after toxin activity has exposed the fibronectin and
collagen [39,69,70]. CD2831 may also aid virulence by inhibiting the formation of the C1 com-
plement complex by binding to the C1q component of the host complement pathway [39],
thereby limiting the host’s immune response. This observation is important for understanding
of the pathogenesis of C. difficile infection and disease as it suggests that CD2831 and CpbA
could be responsible for C. difficile adherence to the gut epithelium via host collagen exposed
through the action of C. difficile toxins, while at the same time possibly limiting the immune
response.
Toxin production in C. difficile biofilms
C. difficile tcdA and tcdB genes encode toxin A and toxin B proteins, respectively, and are
located within the pathogenicity locus (PaLoc) of the genome [71]. The other genes required
for toxin synthesis are also encoded within PaLoc; tcdR and tcdC are both involved in regula-
tion and tcdE, which has a role in toxin secretion [72,73]. Toxin production by C. difficile is
positively controlled by up-regulation of tcdR expression by effect of sigma factor sigD (origi-
nally annotated and named by Aubry and colleagues as fliA) [74,75]. However, sigD is nega-
tively controlled by c-di-GMP levels and is also responsible for regulation of the fliC gene [74].
Consequently, sigD has been identified as a key virulence regulator as it can lead to decreased
expression of both flagella and toxin production under elevated c-di-GMP levels [74].
An RNA-seq comparison of gene expression in C. difficile R20291 biofilm and planktonic
cultures revealed a statistically significant increase in tcdB expression by 2.83-fold (q< 0.05) in
biofilms compared to planktonic culture, but without a corresponding increase in tcdA expres-
sion [38]. However, when comparing toxin expression in biofilm compared to colony growth,
both tcdA and tcdB exhibited significant decreases in expression in the biofilm culture (by
3.25-fold and 2.89-fold, respectively) [38]. Differential expression of tcdA and tcdB was also
found in C. difficile 630Δerm biofilms grown in a continuous-flow microfermentor for 72
hours [52]. However, in this case, tcdA expression had decreased by only 1.03-fold, and tcdB
expression was not significantly different [52]. The reported differences between these studies,
with respect to the bacterial strains used, culture conditions, and time of RNA extraction make
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direct comparisons difficult. However, it raises the possibility that, under comparable condi-
tions, the 2 strains may well behave similarly with regard to toxin gene expression in biofilms
[38,42,76].
In C. difficile 630 cells cultured in human faecal water, expression of tcdA was decreased by
4-fold (p< 0.001) [77]. It was suggested that this was due to a decrease in metabolism of carbo-
hydrates into butyrate [77]. Nonetheless, while toxin expression decreased in the presence of
FW, the expression of sporulation genes significantly increased—by up to 300-fold in some
cases [77]. This indicates that FW components induce sporulation, potentially aiding the trans-
mission of C. difficile, but that FW components alone do not necessarily play a role in disease
onset by inducing toxin production [77].
Sporulation in C. difficile
C. difficile produces metabolically dormant structures called spores that are resistant to oxygen
and heat stress as well as some disinfecting agents [78,79]. Spores, as the transmissible agent,
are therefore important for the spread of C. difficile as they allow the pathogen to survive out-
side of the host [78–80]. The Spo0A master regulator in B. subtilis is responsible for driving 3
possible pathways: sporulation, production of an extracellular matrix, or production of toxins,
which sacrifice some cells in order to gain nutrients, a process referred to as cannibalism
[20,36,81–83]. Low levels of phosphorylated Spo0A causes matrix production in B. subtilis,
whereas increasing phosphorylation results in spore production [81]. Disruption of spo0A in
C. difficile strain R20291 resulted in complete inhibition of sporulation and significantly
smaller biofilms than the parent strain at 3 and 6 days (p< 0.05) when grown in microtiter
plates as measured by crystal violet assay [20]. These smaller spo0A mutant biofilms were more
easily detached and dispersed when gently agitated in tissue culture flasks, compared to the
parent strain biofilm [20]. This reduction in biofilm in the C. difficile R20291 Spo0A mutant
led the authors to conclude that the role of spo0A in C. difficile is analogous to that of the
Spo0A regulator in B. subtilis [20]. However, the effects on biofilm formation and dispersal
could also be an indication that the spo0A regulator mutation influences other processes such
as adherence, an aspect not examined by Dawson and colleagues in their 2012 paper [20].
A more recent study by Dawson and colleagues examined sporulation frequency within
biofilms for 5 C. difficile strains including 630 and R20291 and found similarities in biofilm
composition between strains [62]. A positive correlation between sporulation frequency and
biofilm biomass was found along with a positive correlation with eDNA in the matrix [62]. It
was suggested that the increased eDNA and sporulation correlating with increased biofilm bio-
mass could arise from induction of sporulation within the biofilms resulting in cell lysis to
release eDNA and intracellular proteins into the matrix [62]. The importance of eDNA as a
key component in C. difficile biofilms was proven by successful inhibition and disruption of C.
difficile biofilms using DNase enzymes [35,62]. However, identification of other proteins in
the matrix, namely Cwp19 and phage protein (phiCD24-1), which both contribute to cell lysis
and so would also elevate eDNA, indicates a complexity to the biofilm formation process and
can explain why disruption of single genes cannot produce an all-or-nothing biofilm pheno-
type where many processes are involved [62]. Additionally, the authors also found that 630
and R20291 had significantly greater numbers of spores in their biofilms, compared to plank-
tonic supernatants, which were suggested to aid recurrence of infection through dispersal of
the biofilm and reseeding spores elsewhere in the gut [62].
A study performed by Tijerina-Rodrı́guez and colleagues to determine the differences in
recurrent-CDI (R-CDI) cases and nonrecurrent-CDI (NR-CDI) clinical samples found that
there was no significant difference in distribution of C. difficile ribotypes between R-CDI and
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NR-CDI samples; however, 81% of 102 samples examined contained RT-027 strains of C. diffi-
cile [84]. Significantly higher rates of sporulation were found in R-CDI isolates compared to
NR-CDI isolates grown in 7-day mono-biofilms (p = 0.015), which corresponded with R-CDI
biofilms having higher expression of both spo0A and sigH, the alternative sigma factor for con-
trolling sporulation [84]. This also fits with the theory of Dawson and colleagues discussed
above that biofilms with increased sporulation frequency can reseed and lead to recurrent
infections [62]. Crucially, however, there was no significant difference in biofilm formation
between the 2 groups (R-CDI and NR-CDI) at 7 days as measured by the crystal violet assay
[84]. This suggests that increased spo0A expression does not influence biofilm formation sig-
nificantly and that sporulation may play a larger role in recurrence of disease than biofilm for-
mation [84].
The role of the stress response in C. difficile biofilms
Bacteria respond to stressors, such as adverse and fluctuating conditions, by altering gene
expression to adapt to new environments [85]. Biofilm formation by bacteria is recognised as a
stress response, as the production of an extracellular matrix shields the bacterial cells from
external pressures such as oxygen stress and antibiotics [20,86–88]. Several factors within the
biofilm can contribute to recalcitrance to antibiotics such as polarity of the matrix inhibiting
drug diffusion and reduced metabolic activity within the cells preventing antibiotic uptake
into the cells [27].
Subinhibitory antibiotic concentrations are known to cause a stress response in many bac-
teria including Escherichia coli, Vibrio cholerae, and Staphylococcus aureus, where they also
lead to increased expression of virulence factors [89]. C. difficile strains that showed suscepti-
bility to antibiotics such as metronidazole produced significantly more biofilm in the presence
of subinhibitory concentrations of this antibiotic [86,90]. The regulatory processes and mecha-
nism underpinning this observation were not confirmed in these studies; however, subinhibi-
tory concentrations of antibiotics have been found to trigger the stress response in other
bacteria [89]. Consequently, treatment of CDI with lower concentrations of ineffective antibi-
otics could worsen the disease state or lead to recurrence.
A pattern of stress responses inducing morphological changes is seen in many bacterial spe-
cies [89]. For example, a disruption mutation in the prkC gene in 630Δerm resulted in the
mutant producing significantly increased biofilm under bile salt–induced stress conditions
(p< 0.05) [57]. The prkC gene encodes a membrane-associated serine/threonine (SerAU : PleasenotethatSer=Thrhasbeendefinedasserine=threonineinthesentenceTheprkCgeneencodesamembrane   associatedserine=threonineðSer=ThrÞ:::Pleasecorrectifnecessary:/Thr)
kinase enzyme with 2 penicillin-binding and Ser/Thr kinase-associated (PASTA) domains, but
its function is, as yet, uncharacterised in C. difficile [57]. The prkC mutant strain produced sig-
nificantly increased biofilm after 24 hours, but only in the presence of compounds that stressed
the cell envelope, such as the bile salt DOC, or the antibiotic polymyxin B [57]. Other effects
caused by the mutation were a>100% elongation of the cells, in which abnormal septa were
identified by confocal and transmission electron microscopy, along with replication defects,
reduced motility, and increased aggregation [57].
The DnaK protein is also an important component of the C. difficile stress response and has
also been found in the biofilm matrix [58,62]. It is a molecular chaperone that aids protein
folding and is up-regulated under heat stress conditions [91]. A ClosTron insertion mutation
in the dnaK gene of 630Δerm disrupted DnaK production and generated a less thermotolerant
strain that exhibited suboptimal growth at 37˚C and reduced motility due most likely to the
lack of flagella on the cell surface as revealed by TEM [58]. However, disruption of the dnaK
gene also resulted in a significant increase in biofilm formation, as well as approximately 50%
elongation of the cells into filamentous rods [58].
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Similar effects were seen when other elements of the C. difficile stress response were investi-
gated. The SOS response is a regulatory network within the stress response of bacterial cells
that reacts to cellular damage and, in particular, DNA damage [41,85,89]. The SOS response is
regulated by proteins LexA and RecA [89]. The global transcriptional repressor, LexA, tempo-
rarily halts cellular division in C. difficile and activates processes for cellular DNA repair
[41,92]. Disruption of the lexA gene in C. difficile R20291 resulted in elongated, filamentous
cells, as well as increased biofilm production compared to the parent strain [41]. These obser-
vations are similar to those made with the dnaK mutant in 630Δerm, thus emphasising the
effects of stress on biofilm formation [58].
While physiological stress is clearly implicated in biofilm formation, other signalling pro-
cesses initiated by favourable growth conditions that result in an increase in cell number and
density are also present in bacteria [93,94]. This method of communication is referred to as
quorum sensing (QS).
The role of quorum sensing in C. difficile biofilms
QS is a system that regulates gene expression in bacterial cells by using signalling molecules
called autoinducers that build up as a direct result of increasing cell population density [93,94].
The LuxS QS system exists in both gram-positive and gram-negative bacteria and uses signal-
ling molecules collectively known as autoinducer-2 (AI-2) [95,96]. AI-2 molecules act on cell
surface receptors not yet identified in C. difificile to generate an intracellular signalling cascade
that results in gene regulation (Fig 3) [42,95,96].
A luxS ClosTron mutant in the hypervirulent C. difficile strain R20291 was defective in
production of AI-2 molecules, as measured by induction of bioluminescence in the biore-
porter strain Vibrio harveyi BB170, which responds only to AI-2 signals [42,97]. As a
result of this mutation in luxS, the mutant R20291 was also deficient in biofilm formation
[42]. Chemical complementation using the compound 4,5-dihydroxy-2,3-pentanedione
(DPD), which spontaneously and reversibly forms AI-2, showed that a concentration of
100 nM DPD could restore biofilm formation to WT levels, thereby confirming that both
AI-2 and LuxS are involved in biofilm formation in C. difficile [42,95]. However, the
receptor for AI-2 in C. difficile has yet to be identified [42]. RNA-seq analysis of gene
expression in the R20291 luxS mutant biofilm cells revealed 3 genes with increased expres-
sion: CDR20291_2554 (crr), a PTS system glucose-specific transporter subunit IIA;
CDR20291_2927, a cellobiose phosphate-degrading protein; and CDR20291_2930 (treA),
a trehalose-6-phosphate hydrolase [42]. A total of 18 genes exhibited decreased expression
compared to the WT; these genes corresponded, in the main, to 2 putative prophage
regions [42]. The prophage regions, therefore activated by AI-2, have been linked to
induction of cell lysis that produces eDNA, which, as mentioned above, is necessary for
biofilm formation in C. difficile [36,42,62,98].
However, a separate study that investigated gene expression in biofilms, planktonic cells,
and colony-grown C. difficile R20291 reported no significant difference in expression of the
luxS gene between the growth models [38]. It was suggested that this could be due to the RNA
being extracted from a 7-day-old biofilm in the later stages of growth, where it might be
expected that there would be differences in gene expression compared to the early stages of
biofilm formation [38]. AI-2 production by planktonic C. difficile has been shown to increase
to a maximum at 8 hours, correlating to mid to late log phase of growth, declining thereafter
[76]. Lee and Song did not, however, investigate biofilm formation alongside this observation.
Biofilm initiation in C. difficile has been shown to occur between 6 and 12 hours, which could
feasibly correlate with the peak in AI-2 seen at 8 hours [38,42,76,90].
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In hypervirulent C. difficile strains such as those belonging to RT-017 or RT-027, the whole
agr operon, agrACDB (agr2), encodes another QS system [53,99,100]. This is similar to the agr
QS locus, agrACDB in S. aureus, which is a global regulator of virulence gene expression [99].
However, the partial locus, agrDB (agr1), has been found in all C. difficile genomes analysed to
date [53,100]. The agr2 QS system uses the small secreted cyclic autoinducing peptide (AIP)
encoded by agrD, which is processed and exported by the transmembrane protein encoded by
agrB [99]. A study investigating the difference between clinical isolates of C. difficile from
R-CDI cases and NR-CDI cases found no significant difference in biofilm formation between
the 2 groups but found a significant increase in sporulation in R-CDI isolate biofilms
(p = 0.015) [84]. There was also no significant difference in luxS expression; however, agrD1
expression was significantly increased by 14.02 relative to 16S rRNA expression (p = 0.001) in
R-CDI isolates when compared to NR-CDI isolates [84].
The agr QS system has also been associated with toxin regulation as allelic exchange dele-
tion mutants of agrB1D1 in the agr1 partial locus of 630 and R20291 were deficient in both
toxin A and B production [100]; an agrA insertional inactivation (ClosTron) mutation in
R20291 also resulted in significantly reduced expression of tcdA compared to the parent
R20291 strain as well as reduced flagellar operon expression [99]. On the other hand, an
Fig 3. Overview of the LuxS QS system in both gram-negative and gram-positive bacteria. Both systems use the same
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R20291 luxS disruption mutant deficient in AI-2 production exhibited no change in toxin
RNA expression compared to the WT, indicating that the LuxS QS system has perhaps mini-
mal influence on toxin production in C. difficile [42]. This is reinforced by the differences in
expression of tcdA and tcdB when luxS expression remains unchanged in R20291 biofilms
grown for 7 days on glass beads [38].
The insertion mutation in the agrA gene of C. difficile strain R20291 also resulted in
decreased expression of 3 genes encoding diguanylate cyclase (DGC) and phosphodiesterase
(PDE) enzymes responsible for c-di-GMP production [99]. This implies that the agr QS system
is also involved with in regulation of production of c-di-GMP [99].
The regulation of c-di-GMP in C. difficile
Soutourina and colleagues hypothesised that biofilm formation and motility in C. difficile is
controlled by c-di-GMP acting on riboswitches, a type of small noncoding RNA molecule
which, in C. difficile and other bacteria, act directly or indirectly on mRNA to control protein
production [39,45–47]. Upon binding of c-di-GMP to a riboswitch, transcription of the associ-
ated mRNA molecule can be decreased by premature termination or positively controlled via a
complex alternative splicing mechanism [47]. Small increases of 2- to 6-fold in intracellular
concentrations of c-di-GMP by a nisin-inducible plasmid in strain 630 compared to empty
vector control have been shown to be sufficient to cause a change in gene expression in C. diffi-
cile as exemplified by a significant reduction in swarming motility [101]. However, it has also
been reported that cellular response to c-di-GMP levels within the cell can vary between C. dif-
ficile strains, for example, R20291 and 630, as R20291 has some of the lowest number of meta-
bolic genes controlled by c-di-GMP [101,102]. Intracellular c-di-GMP levels are controlled by
the actions of DGC and PDE enzymes [45].
A nisin-inducible plasmid overexpressing dccA, encoding a DGC enzyme responsible for
the conversion of 2 guanosine triphosphate (GTP) molecules into c-di-GMP, has been used to
increase intracellular c-di-GMP levels [45,102]. Artificial fluctuations in intracellular c-di-
GMP concentration have been shown to influence swimming motility and flagellar gene
expression, as well as aggregation and type IV pili in 630Δerm (Table 2); therefore, it is unsur-
prising that increasing intracellular c-di-GMP concentrations significantly increased biofilm
Table 2. Changes in c-di-GMP riboswitch-controlled gene expression resulting from increased intracellular c-di-GMP in Clostridioides difficile strain 630Δerm.
Class Riboswitch Downstream gene Encoded protein Fold change
Class I Cdi-1-1 CD1990 SH3 domain containing protein 31.09
Cdi-1-2 CD2797 Calcium binding adhesion protein −7.14
Cdi-1-3 CD0245 FlgB operon encoding 29 flagellar genes −15.06
Cdi-1-8 CD19903 Hypothetical protein −7.78
Cdi-1-9 CD2309 Hypothetical protein −4.66
Cdi-1-11 CD33682 Hypothetical protein −8.90
Cdi-1-12 CD2830 Zmpl/PPEP-1 −62.61
Class II Cdi-2-1 CD3246 Cell surface protein 4.29
Cdi-2-2 CD3267 Two-component response regulator 18.78
Cdi-2-3 CD2831 Putative adhesin predicted to bind collagen 42.51
Cdi-2-4 CD3513 Type IV pili (PilA1) 11.74
Fold changes in gene expression were measured by microarray analysis of planktonically grown 630Δerm expressing plasmid encoded pDccA compared to a vector
control. Plasmid induced expression of dccA by 1 μg/ml nisin was used to increase intracellular c-di-GMP levels. (Adapted from [45]).
c-di-GMP, cyclic diguanosine monophosphate; PPEP-1, pro-pro endopeptidase-1; Zmpl, zinc-dependent metalloprotease.
https://doi.org/10.1371/journal.ppat.1009817.t002
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formation at 24 hours as measured by crystal violet staining [8,45,59,60,101]. A plasmid con-
taining dccA induced by anhydrotetracycline (ATc) was used to increase c-di-GMP levels in
strain 630 [62]. A significant increase in early biofilm formation at 24 hours was found
(p< 0.001 with 25 ng/ml ATc), but by 72 hours, the mature biofilms with increased c-di-GMP
showed no significant increase in biofilm formation compare to the WT [62]. Therefore, it was
concluded that c-di-GMP plays a greater role in early biofilm formation rather than the later
stages [62]. However, other effects of artificially increasing intracellular c-di-GMP have also
been reported such as defective cell separation, resulting in chains of C. difficile cells with
abnormal septa, similar to the cell elongation mentioned above in dnaK, lexA, prkC, and lcpB
mutant strains, which all exhibited increased biofilm formation [41,44,57,58,66].
It is unknown if the extent of the artificial increase in intracellular c-di-GMP by the induc-
ible plasmid is likely under physiological conditions, so what is seen could be an overestima-
tion of the effects, whereas the observations of gene expression within a biofilm model, in
which c-di-GMP was not artificially influenced, could represent a more realistic assessment of
the effects of c-di-GMP [45,52]. Some studies have reported undetectable levels of c-di-GMP
in strain 630 using liquid chromatography–tandem mass spectrometry (LCAU : PleasenotethatLC   MS=MShasbeendefinedasliquidchromatography   tandemmassspectrometryinthesentenceSomestudieshavereportedundetectablelevelsofc   di   GMP:::Pleasecorrectifnecessary:–MS/MS) with a
limit of detection of 0.5 ng/mg dry weight [66]. Nonetheless, Purcell and colleagues recorded
levels of c-di-GMP in planktonic C. difficile 630 cells to be 15 to 50 nM, which is low in com-
parison to other bacteria [101,103].
The effect of nutrient availability on intracellular c-di-GMP concentrations could explain
why C. difficile biofilm formation is enhanced in the presence of glucose in the media [8,90].
Nutrient availability modulates CodY (CD1275), a transcriptional repressor that is activated
by GTP [8]. However, GTP is also required to make c-di-GMP in a process that is regulated by
PdcA, a PDE enzyme that degrades c-di-GMP [8]. Interestingly, the PdcA enzyme is also regu-
lated by CodY but is dependent on GTP concentrations [8]. Therefore, at low GTP levels,
PdcA transcription is active to produce PdcA enzyme molecules, which break down c-di-GMP
into GTP. However, with high GTP levels, CodY is activated and acts to down-regulate PdcA
transcription to prevent PdcA enzyme-mediated degradation of c-di-GMP in a negative feed-
back loop. CodY has also been found to bind to the tcdR toxin gene promoter in the presence
of GTP, also linking increased toxin expression to elevated nutrient availability [104]. Conse-
quently, increasing nutrient availability increases c-di-GMP levels, which can, in turn, act on
relevant riboswitches to promote biofilm formation in C. difficile [8,45].
Regulation of dccA, a DGC that synthesises c-di-GMP and CD1412, a putative PDE that
degrades c-di-GMP, has also been linked to the CD2214-2215 two-gene operon [45,47,52]. In
630, CD2214 encodes a protein homologous to the biofilm and sporulation repressor, sinR,
from B. subtilis [52,105]. When disrupted by ClosTron mutagenesis in strain 630Δerm, the
CD2214-2215 two-gene operon was found to regulate many pathways including sporulation,
the stress response, toxin synthesis, and membrane transport as well as metabolism and motil-
ity potentially through the effects of c-di-GMP [52,106]. Therefore, it has been suggested that
the CD2214-CD2215 two-gene operon could be responsible for the regulation of some 15% of
genes that are differentially expressed in biofilm formation, including genes involved in cellu-
lar metabolism and transition between growth stages [52].
Conclusions
Biofilm formation and bacterial over growth in the gut is a serious threat because of increasing
antibiotic resistance, making treatments less effective [107]. The complexity of C. difficile bio-
film regulation and the differences between strains clearly indicate that there will almost cer-
tainly be no “silver bullet” solution to this growing and challenging problem. This review is
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timely in that it has identified stark differences in regulatory systems between the most
intensely investigated C. difficile strains, namely 630 and R20291, making it difficult to assign a
“one size fits all” paradigm to biofilm regulation in this important organism. Although R20291
has a lower number of metabolic genes controlled by c-di-GMP than 630 [101,102], there
appears to be a regulatory link between c-di-GMP and the full agr1 QS system that is found in
R20291, which is not found in 630 [99]. In addition, opposite effects on biofilm formation in
disruption mutants of cwp84 in both 630Δerm and R20291 have been observed [36,37], and
there is what appears to be a more vital role for type IV pili in R20291 biofilm formation when
compared to 630 [60]. Variation in flagellar machinery and associated genes has also been
observed between R20291 and 630 strains with respect to arrangement and posttranscriptional
modifications as well as phase variation capabilities [55]; however, we can conclude that flagel-
lar genes, and functional flagella, are down-regulated in biofilms [38,52].
The lack of studies to confirm observations made by individual research groups makes it
difficult to conclude an absolute pathway for biofilm regulation. Perhaps, importance should
be placed on focusing efforts to elucidate the biofilm formation pathway in few select C. diffi-
cile strains before expanding research to increasing numbers of strains with highly variable
results. The use of gene expression studies should, in future, allow us to learn more about bio-
film regulation in different C. difficile strains, with the potential for development of improved
treatment options for this opportunistic pathogen.
References
1. Sebaihia M, Wren BW, Mullany P, Fairweather NF, Minton N, Stabler R, et al. The multidrug-resistant
human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet. 2006; 38:779–
786. Available from: https://www.nature.com/articles/ng1830. https://doi.org/10.1038/ng1830 PMID:
16804543
2. Vedantam G, Clark A, Chu M, McQuade R, Mallozzi M, Viswanathan VK, et al. Clostridium difficile
infection: Toxins and non-toxin virulence factors, and their contributions to disease establishment and
host response. Gut Microbes. 2012:121–34. https://doi.org/10.4161/gmic.19399 PMID: 22555464
3. Gould LH, Limbago B. Clostridium difficile in food and domestic animals: A new foodborne pathogen.
Clin Infect Dis. 2010:577–582. https://doi.org/10.1086/655692 PMID: 20642351
4. Songer JG, Anderson MA. Clostridium difficile: An important pathogen of food animals. Anaerobe.
2006:1–4. https://doi.org/10.1016/j.anaerobe.2005.09.001 PMID: 16701605
5. Hensgens MPM, Keessen EC, Squire MM, Riley TV, Koene MGJ, De Boer E, et al. Clostridium difficile
infection in the community: A zoonotic disease? Clin Microbiol Infect. Blackwell Publishing Ltd.
2012:635–45. https://doi.org/10.1111/j.1469-0691.2012.03853.x PMID: 22536816
6. Buffie CG, Jarchum I, Equinda M, Lipuma L, Gobourne A, Viale A, et al. Profound alterations of intesti-
nal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium
difficile-induced colitis. Infect Immun. 2012; 80:62–73. https://doi.org/10.1128/IAI.05496-11 PMID:
22006564
7. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut
microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A. 2011; 108:4554–61. https://
doi.org/10.1073/pnas.1000087107 PMID: 20847294
8. Purcell EB, McKee RW, Courson DS, Garrett EM, McBride SM, Cheney RE, et al. A nutrient-regulated
cyclic diguanylate phosphodiesterase controls Clostridium difficile biofilm and toxin production during
stationary phase. Infect Immun. 2017; 85. https://doi.org/10.1128/IAI.00347-17 PMID: 28652311
9. CDC. Antibiotic resistance threats in the United States. US Dep Heal Hum Serv CDC. 2019. http://dx.
doi.org/10.15620/cdc:82532
10. Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, et al. Burden of Clostridium diffi-
cile infection in the United States. N Engl J Med. 2015; 372:825–34. https://doi.org/10.1056/
NEJMoa1408913 PMID: 25714160
11. De Roo AC, Regenbogen SE, De Roo AC, Regenbogen SE. Clostridium difficile Infection: An Epidemi-
ology Update. Clin Colon Rectal Surg. 2020; 33:49–57. https://doi.org/10.1055/s-0040-1701229
PMID: 32104156
PLOS PATHOGENS
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1009817 September 9, 2021 15 / 20
12. Guh AY, Mu Y, Winston LG, Johnston H, Olson D, Farley MM, et al. Trends in U.S. Burden of Clostri-
dioides difficile Infection and Outcomes. N Engl J Med. 2020; 382:1320–30. https://doi.org/10.1056/
NEJMoa1910215 PMID: 32242357
13. Kampouri E, Croxatto A, Prod’hom G, Guery B. Clostridioides difficile Infection. Still a Long Way to Go.
J Clin Med. 2021; 10:389. https://doi.org/10.3390/jcm10030389 PMID: 33498428
14. Suetens C, Latour K, Kärki T, Ricchizzi E, Kinross P, Moro ML, et al. Prevalence of healthcare-associ-
ated infections, estimated incidence and composite antimicrobial resistance index in acute care hospi-
tals and long-term care facilities: Results from two european point prevalence surveys, 2016 to 2017.
Eur Secur. 2018; 23:1800516. https://doi.org/10.2807/1560-7917.ES.2018.23.46.1800516 PMID:
30458912
15. Tresman R, Goldenberg SD. Healthcare resource use and attributable cost of Clostridium difficile
infection: A micro-costing analysis comparing first and recurrent episodes. J Antimicrob Chemother.
2018; 73:2851–5. https://doi.org/10.1093/jac/dky250 PMID: 29982502
16. Cornely OA, Miller MA, Louie TJ, Crook DW, Gorbach SL. Treatment of first recurrence of clostridium
difficile infection: Fidaxomicin versus vancomycin. Clin Infect Dis. 2012; 55. https://doi.org/10.1093/
cid/cis462 PMID: 22752865
17. Guery B, Menichetti F, Anttila VJ, Adomakoh N, Aguado JM, Bisnauthsing K, et al. Extended-pulsed
fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older
(EXTEND): a randomised, controlled, open-label, phase 3b/4 trial. Lancet Infect Dis. 2018; 18:296–
307. https://doi.org/10.1016/S1473-3099(17)30751-X PMID: 29273269
18. Zhang S, Palazuelos-Munoz S, Balsells EM, Nair H, Chit A, Kyaw MH, et al. Cost of hospital manage-
ment of Clostridium difficile infection in United States-a meta-analysis and modelling study. BMC Infect
Dis. 2016; 16. https://doi.org/10.1186/s12879-016-1786-6 PMID: 27562241
19. Balsells E, Shi T, Leese C, Lyell I, Burrows J, Wiuff C, et al. Global burden of Clostridium difficile infec-
tions: A systematic review and meta-analysis. J Glob Health. 2019; 9. https://doi.org/10.7189/jogh.09.
010407 PMID: 30603078
20. Dawson LF, Valiente E, Faulds-Pain A, Donahue EH, Wren BW, Popoff MR. Characterisation of Clos-
tridium difficile Biofilm Formation, a Role for Spo0A. PLoS ONE. 2012; 7. https://doi.org/10.1371/
journal.pone.0050527 PMID: 23236376
21. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet. 2001:135–8. https://
doi.org/10.1016/s0140-6736(01)05321-1 PMID: 11463434
22. Davey ME, O’Toole GA. Microbial Biofilms: from Ecology to Molecular Genetics. Microbiol Mol Biol
Rev. 2000; 64:847–67. https://doi.org/10.1128/MMBR.64.4.847-867.2000 PMID: 11104821
23. Whitchurch CB, Tolker-Nielsen T, Ragas PC, Mattick JS. Extracellular DNA required for bacterial bio-
film formation. Science. 2002; 295:1487. https://doi.org/10.1126/science.295.5559.1487 PMID:
11859186
24. Kavanaugh JS, Flack CE, Lister J, Ricker EB, Ibberson CB, Jenul C, et al. Identification of extracellular
DNA-binding proteins in the biofilm matrix. mBio. 2019;10. https://doi.org/10.1128/mBio.01137-19
PMID: 31239382
25. Shrout JD, Chopp DL, Just CL, Hentzer M, Givskov M, Parsek MR. et al. The impact of quorum sens-
ing and swarming motility on Pseudomonas aeruginosa biofilm formation is nutritionally conditional.
Mol Microbiol. 2006; 62:1264–77. https://doi.org/10.1111/j.1365-2958.2006.05421.x PMID: 17059568
26. Rossi E, Paroni M, Landini P. Biofilm and motility in response to environmental and host-related sig-
nals in Gram negative opportunistic pathogens. J Appl Microbiol. Blackwell Publishing Ltd.
2018:1587–602. https://doi.org/10.1111/jam.14089 PMID: 30153375
27. Lebeaux D, Ghigo J-M, Beloin C. Biofilm-Related Infections: Bridging the Gap between Clinical Man-
agement and Fundamental Aspects of Recalcitrance toward Antibiotics. Microbiol Mol Biol Rev. 2014;
78:510–43. https://doi.org/10.1128/MMBR.00013-14 PMID: 25184564
28. Bjarnsholt T. The role of bacterial biofilms in chronic infections. APMIS Suppl. 2013:1–51. https://doi.
org/10.1111/apm.12099 PMID: 23635385
29. Rasamiravaka T, Labtani Q, Duez P, El Jaziri M. The formation of biofilms by pseudomonas aerugi-
nosa: A review of the natural and synthetic compounds interfering with control mechanisms. Biomed
Res Int. 2015. https://doi.org/10.1155/2015/759348 PMID: 25866808
30. Normington C, Moura IB, Bryant JA, Ewin DJ, Clark EV, Kettle MJ, et al. Biofilms harbour Clostri-
dioides difficile, serving as a reservoir for recurrent infection. NPJ Biofilms Microbiomes. 2021; 7.
https://doi.org/10.1038/s41522-021-00184-w PMID: 33547298
31. Soavelomandroso AP, Gaudin F, Hoys S, Nicolas V, Vedantam G, Janoir C, et al. Biofilm structures in
a mono-associated mouse model of Clostridium difficile infection. Front Microbiol. 2017; 8. https://doi.
org/10.3389/fmicb.2017.02086 PMID: 29118745
PLOS PATHOGENS
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1009817 September 9, 2021 16 / 20
32. Spencer J, Leuzzi R, Buckley A, Irvine J, Candlish D, Scarselli M, et al. Vaccination against Clostrid-
ium difficile using toxin fragments: Observations and analysis in animal models. Gut Microbes. 2014;
5:225–32. https://doi.org/10.4161/gmic.27712 PMID: 24637800
33. Semenyuk EG, Poroyko VA, Johnston PF, Jones SE, Knight KL, Gerding DN, et al. Analysis of bacte-
rial communities during Clostridium difficile infection in the mouse. Infect Immun. 2015; 83:4383–91.
https://doi.org/10.1128/IAI.00145-15 PMID: 26324536
34. Buckley AM, Spencer J, Candlish D, Irvine JJ, Douce GR. Infection of hamsters with the UK clostrid-
ium difficile ribotype 027 outbreak strain R20291. J Med Microbiol. 2011; 60:1174–80. https://doi.org/
10.1099/jmm.0.028514-0 PMID: 21330415
35. Dubois T, Tremblay YDN, Hamiot A, Martin-Verstraete I, Deschamps J, Monot M, et al. A microbiota-
generated bile salt induces biofilm formation in Clostridium difficile. NPJ Biofilms Microbiomes. 2019;
5. https://doi.org/10.1038/s41522-019-0087-4 PMID: 31098293
36. Dapa T, Leuzzi R, Ng YK, Baban ST, Adamo R, Kuehne SA, et al. Multiple factors modulate biofilm for-
mation by the anaerobic pathogen Clostridium difficile. J Bacteriol. 2013; 195:545–55. https://doi.org/
10.1128/JB.01980-12 PMID: 23175653
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